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WHO WE ARE
Mission
Create the future of health through pharmacy.

Vision
Excellence through leadership

Organizational values
We value: service to the local, national and
global community; integrity and ethical
behavior; innovation and collaboration in
research; professional practice and education;
personal growth through lifelong learning;
diversity and respect for all individuals; cultural
competence.

URI COLLEGE OF PHARMACY

DEAN’S MESSAGE
As educators in a medical field, I’ve always felt that we in
the College of Pharmacy serve more than the students who
roam our halls. We are also dedicated to the world outside
the University through our research and know that the work
we produce in our labs at Avedisian Hall should have a
lasting impact throughout the health system.
Looking back over the past year, it’s clear the College
has made great strides in accomplishing both those goals
— educating the next generation of pharmacists and
pharmaceutical scientists, and making major contributions
to the overall health of our society. The pages of this report
detail just some of those accomplishments.
Perhaps nothing better exemplifies our commitment to
innovation than the college being ranked 11th in the nation
in federal research funding. We have made a concerted
effort to invest in our research, a commitment that is
continuing into the new academic year. Our professors are
working on, innovative treatments to fight cancer, battle the
devastating effects of alcohol use disorder, expand HIV
treatment and prevention methods, and find ways to use
natural, holistic methods to treat a host of ailments.
The successes highlighted in the following pages are
just a few of the ways our faculty members are working to
impact the community. That same dedication is evident in
the classroom, inspiring students to collaborate on projects
and pursue their own innovations. Our students have
received research awards of their own, been honored
nationally for their service in the community, completed
health services missions in foreign lands and lobbied state
officials on important pharmaceutical issues. Our recent
graduates have achieved impressive board pass rates,
secured residency positions at a clip well above the
national average, and nearly unanimously found
employment immediately upon graduation.
The past few years have seen the College enhance its
status as a leader in the pharmaceutical, biomedical and
health industries, momentum that will continue in coming
years. We hope you are as excited as we are to look back
on the achievements of the past year and look forward to
the major accomplishments to come.
–Dean E. Paul Larrat
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Pharm. D. by the numbers
INCOMING CLASS OF 2024

1312

AVERAGE
SAT

775

UNDERGRADUATE Pharmacy
STUDENTS ENROLLED FOR FALL 2018

4.10

AVERAGE
GPA
OF INCOMING
CLASS

SCORE OF INCOMING
CLASS

STUDENTS ARE FROM
15 STATES

B.S.P.S. by the numbers
INCOMING CLASS OF 2022

1173

3.30

AVERAGE
SAT

AVERAGE
GPA

SCORE OF INCOMING
CLASS

STUDENTS ARE FROM:
6 STATES AND 2 FOREIGN
COUNTRIES

OF INCOMING
CLASS

Pharm. D.
CLASS OF 2018

96.7%

RATE OF IMMEDIATE
EMPLOYMENT AMONG
2018 GRADUATES
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94%

NAPLEX
FIRST-TIME
PASS RATE

Residency Placements
The URI College of Pharmacy consistently ranks among the top pharmacy schools in the
country for post-graduate residency matches. The Class of 2018 has achieved an overall
success rate of 80 percent, outpacing the national average of 65 percent, according to the
American Society of Health-System Pharmacists.
URI students have been placed in the following locations:
Baystate Medical Center, Springfield, MA
Boston Medical Center, Boston, MA
Cambridge Health Alliance, Cambridge, MA
Cape Regional Medical Center, Cape May Court House, NJ
CVS Health, Lincoln, RI
Department of Veterans Affairs Medical Center-Lebanon,
Lebanon, PA
Eastern Maine Medical Center, Bangor, ME
Henry Ford Hospital, Detroit, MI
Holyoke Health Center Pharmacy, Holyoke, MA
Indian Health Service, Albuquerque Indian Health Center,
Albuquerque, NM
Kaiser Permanente-San Diego, San Diego, CA
Kent County Memorial Hospital, Warwick, RI
Loma Linda University Health, Loma Linda, CA
Maine Medical Center, Portland, ME
Mercer University College of Pharmacy, Atlanta, GA
Rhode Island Hospital, Providence, RI
South County Health, Wakefield, RI
UMass Memorial Medical Center, Worcester, MA
UMass Medical School—Clinical Pharmacy Services,
Shrewsbury, MA

UNC/D-Rex Pharmacy, Jonesville, NC
University Hospitals Portage Medical Center, Ravenna, OH
University of Rhode Island PGY1 Community, Kingston, RI
University of Rochester Medical Center, Rochester, NY
University of Vermont Medical Center, Burlington, VT
US Medical Affairs, Merck & Co, Inc., Kenilworth, NJ
Veterans Affairs Connecticut Healthcare System,
West Haven, CT
Veterans Affairs Maine Healthcare System, Augusta, ME
Veterans Affairs Nebraska-W. Iowa Health Care
System-Grand Island, NE
Veterans Affairs New Jersey Health Care System,
East Orange, NJ
VA Tennessee Valley Healthcare System, Nashville, TN
Veterans Affairs Medical Center-Washington, Washington, D.C.
Veterans Health Care System of the Ozarks, Fayetteville, AR
Western New England University/CoP—Big Y, Springfield, MA
Wolfson Children’s Hospital/Baptist Health, Jacksonville, FL

URI Success Rate: 80% National Average: 65%
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RESEARCH
Dynamic Faculty, Students fuel
Scientific Breakthroughs
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College Ranked 11th nationally in Federal Research Funding
The University of Rhode Island College of Pharmacy is now ranked 11th in the nation in
total federal research grant funding after securing nearly $12 million in federal funds in
fiscal 2017, the latest year for which numbers are available. That ranking — of 138
pharmacy colleges nationwide — is a record for URI.
URI is now the number 1 ranked pharmacy
college in the Northeast in terms of federal
research funding, primarily from the National Institutes of Health, and number 2 on the East Coast.
Only the University of North Carolina at Chapel
Hill ranked higher on the list.
The College had consistently ranked in the 20s
for the preceding five-year period prior to 2017. A

dynamic faculty focused on scientific breakthroughs, along with a
concerted effort to increase grant
funding and research partnerships,
contributed to the move up the
ranks, according to Dean E. Paul Larrat.
“Many of our faculty members are in the middle,
the primes, of their research careers and they’re
really hitting their stride,” Larrat said, noting he
expects the College will maintain the momentum
going forward. “These successful, seasoned
researchers are also mentoring our younger
professors, whose new research funding isn’t
even reflected in the 2017 rank. That’s what
makes this sustainable.”

prevention, health outcomes, neurological health
and the use of natural ingredients like maple in
maintaining health, among a host of other
important subjects. The benefit to the community
of such scientific breakthroughs is obvious, but
the grant funding also helps the College continually improve its educational offerings.
“We harp on our students to make a difference,
and they see our faculty members doing just
that,” Larrat said. “Being able to take salient
discoveries from the research labs and bring that
work into the classrooms is of benefit to our
students; it makes us better teachers, and it
makes our students better scientists and health
providers. The access to work in those labs is
incredibly valuable to our students. And it is
translated into helping the patients we all serve.”

A committee of researchers, led by Professors
Navindra Seeram, Kerry LaPlante, Bongsup Cho
and Angela Slitt meet regularly to strategize
research efforts and target grant funding.
LaPlante recently held a grant funding workshop,
teaching researchers in the Colleges of
Pharmacy, Nursing and Health Sciences as well
as the R.I. Idea Network of Biomedical Research
Excellence (INBRE) program tips on writing grant
applications. Slitt is chairwoman on the URI
Council for Research Grants Program, serving as
a university-wide advocate for grant funding.
The funding fuels critical research in such areas
as drug development, cancer treatment and
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Drug Study Produces ‘Promising
Therapy’ for Alcohol Use Disorder
Alcohol use disorder is among the leading causes of
preventable death in the United States, killing more than
88,000 people a year, according to the Centers for Disease
Control, more than HIV/AIDS, gun violence and car crashes
combined. Despite this, the current medications available to
treat alcohol use disorder are not highly effective.

“We cannot say
this is a cure;
we can say it is
a promising
therapy.”

A URI College of Pharmacy Professor is focusing on
changing that. Fatemah Akhlaghi, PharmD, PhD, is part of a
team working to develop a novel medication to treat the
disorder. Funded by a $1.65 million grant from the National
Center for Advancing Translational Sciences, a branch of
the National Institutes of Health (NIH), Akhlaghi’s team at
URI is testing the safety and efficacy of a drug originally
developed by Pfizer to treat obesity and diabetes.
The drug focuses on ghrelin, a peptide with 28-amino acids
that stimulates appetite and food intake. Known as “the
hunger hormone,” ghrelin levels and feelings of hunger
increase in tandem. In those suffering from alcohol use
disorder, higher concentrations of ghrelin are associated
with higher alcohol craving and consumption. The researchers believe an oral medication that blocks ghrelin may help
stave off the cravings for alcohol. The initial study has
shown positive results in lab rats and in 12 patients who
volunteered for a study at NIH. The result of this study was
published in May 2018 in Molecular Psychiatry.
“Addictions share similar pathways in the brain — food
addiction, alcohol addiction, drug addiction. If this drug can
block the ghrelin receptors, even if you have a high ghrelin
level, your ghrelin receptors become numb and do not
respond to the hunger signal,” said Akhlaghi, co-principal
investigator on the study. “In 12 patients, there was a
statistically significant reduction in alcohol craving and food
craving. We cannot say this is a cure; we can say it is a
promising therapy.”
The researchers are now working on a larger placebo-controlled clinical trial which will further test the medication on
patients with alcohol use disorder. Researchers will study
the effects of the medication on patients’ alcohol cue
responses using functional magnetic resonance imaging to
determine whether the drug has adequate efficacy for
treating disorder.
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Stopping Cancer Before it Starts
A person unknowingly exposed to a carcinogen may live for decades before a cancer
diagnosis is made, giving tumors time to grow and the disease time to develop.
But what if people knew what toxins they’ve been
exposed to in their lifetimes long before a cancer
has begun to form? They could be screened for
the cancers those carcinogens cause and have a
much better chance of tackling the disease before
it turns incurable.

By identifying the damaging patterns
to the genome, we could tell people
they are at risk. They’ll have a better
chance of living longer and living a
better life.”

URI College of Pharmacy Assistant Professor
Deyu Li is trying to give people exactly that
chance, leading a study to identify the mutational
spectra of environmental toxins. Funded by the
$2.1 Million ONES (Outstanding New Environmental Scientist) Award from National Institute of
Environmental Health Sciences, the five-year
study examines the mutational spectra of human
carcinogens.

By collaborating with Professor Bongsup Cho’s
lab in the same department, Li’s study begins with
4-aminobiphenyl and amino-alpha-carboline. The
former is the only known chemical that can cause
human bladder cancer and the latter is a carcinogen that is formed in well-done cooked meat,
diesel gas exhaust and tobacco smoke. He hopes
to identify mutational spectra of the two toxins,
with the goal of eventually mapping many other
carcinogens. Once the mutational spectra are
identified, people who have their genomes
sequenced can know to watch for specific
cancers as they age.

“It’s often a very long time between exposure to a
carcinogen and a diagnosis of cancer,” Li said.
“By then, it’s often too late for the patients. But we
can help them know way earlier than that.
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Pharmacy Professor Wins $2 million Avenir Award
A pharmacy professor’s study that aims to leverage the influence of social networks or
communities among people who use drugs for HIV treatment and prevention was selected
for the 2018 Avenir award for HIV/AIDS research by the National Institute on Drug Abuse.

Assistant Professor Ashley Buchanan is this
year’s awardee and will receive more than $2
million over the next five years to fund her “highly
innovative study,” according to NIDA.
Buchanan’s project is designed to advance HIV
prevention and treatment research by studying
drug users who are part of social networks or
communities that may exert biological or social
influence on their members. Current methodological approaches to estimate and evaluate how
prevention and treatment interventions permeate
a risk network or community of drug users are
limited. Buchanan’s research will improve the
quality of information obtained from network-based studies, helping facilitate interventions by expanding the knowledge base of HIV
preventative and treatment best practices and
leveraging network-based effects to reduce risk
and improve HIV prevention and treatment.
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The study will develop novel statistical methodologies to determine the best ways to reach the most
at-risk people with treatment and information they
need. Intravenous drug users can be supported to
engage in less risky behaviors, such as not
sharing injection equipment, and to get tested for
HIV and seek treatment if needed. Successfully
treating and educating one person helps not only
that individual live a healthier life, but also others
in the social network with whom he or she
interacts.
“The goal ultimately is developing methods that
can help us better understand how these social
connections play a role in the effectiveness of
biological and educational interventions,”
Buchanan said. “The bottom line is understanding
when these effects differ depending on what the
individual’s role is in the network. How can you
design future interventions to better leverage the
beneficial spillover?”

Mind Over Matters
Six weeks of yoga and meditation proved a potent
prescription for students who participated in a
recent College of Pharmacy study.
Conducted by pharmacy student John Hoolahan ’19,
Clinical Associate Professor Virginia Lemay and Assistant
Professor Ashley Buchanan, the study, titled “Samyama:
Stress, Anxiety, Mindfulness: A Yoga and Meditation
Assessment,” found students reporting increased mindfulness coupled with decreased stress and anxiety levels after
a month-and-a-half of weekly practice. Seventeen students
participated. About half of those were pharmacy students.
The students undertook a one-hour vinyasa yoga class,
followed by guided meditation. Students completed questionnaires at the beginning and end of the program,
assessing their stress, anxiety and mindfulness levels.
Hoolahan, who is also a Reiki master, said the study
evolved out of conversations he had with Lemay about
integrating his spiritual life with his academic and professional pursuits. “I

was coming out of a time
when I was very unsure as to what I wanted
to be on this Earth for,” Hoolahan said.
“This showed me I’m capable of merging
these two worlds that I’ve found.”
The popularity of the study — and a spin-off weekly meditation class — have the trio considering what they might do
next. Hoolahan would like to do more research and find a
larger space to make yoga, meditation and Reiki available
to more people.
The need is real, the three agreed.

ANNUAL REPORT 2018 / 9

Student Earns National Award for Work in Public Health
URI College of Pharmacy student Paige Ethier earned national recognition for her
commitment to public health and her work with underserved populations from the
United States, Public Health Service.
Lt. Jessica Newman presented the P4 student with the
Excellence in Public Health Pharmacy Award in Dean E.
Paul Larrat’s office April 18. The Annual Excellence in
Public Health Service presents the award to increase the
public’s awareness of the critical role pharmacists play in
promoting healthy communities.
“This year’s awardee is recognized for her extensive work
with medically underserved populations, including carrying
out educational campaigns for underserved residents of
Rhode Island, staffing immunization clinics and health
screening for incarcerated inmates and developing educational programs for native American tribes,” Lt. Jessica
Newman said. “Pharmacists are trusted health care
providers who have the capability to produce a positive
impact on our nation’s health.”
Ethier, a South Kingstown, R.I., native, has traveled around
the country working with Native American tribes, including
the Cocopah and Quechan tribes in Yuma, Arizona, and the
Cherokee tribe in Oklahoma. She worked as a pharmaceutical intern, helping run immunization clinics, screening for
such conditions as diabetes and hypertension, and
spreading public awareness to prevent the conditions. She
has also done similar work in prisons around the country,
Ethier said she hopes to continue in a career in public health.
Pharmacy Professor Brett Feret nominated Ethier for the
award to recognize the work she has already completed
toward that goal.
“I know she is committed to public health,” Feret said.
“Looking at all she’s done this year and all the work she’s
done in the public health sphere, it just made sense to
nominate her.”

STUDENTS
Prepared to be health
care leaders
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URI pharmacy student Paige Ethier.

“Pharmacists are
trusted health care
providers who
have the capability
to produce a
positive impact
on our nation’s
health.”

College Confers 165 Degrees
Dean E. Paul Larrat urged graduates to always “act
to maintain that trust” patients need to have for their
pharmacists as they embark on their careers after
165 of them received their degrees Sunday, May 20.
“There’s a psychological component to all medications,”
Larrat told the group in his commencement address. “Why
is this? There’s that psychological effect because patients
trust that that medication is going to work; they trust their
prescriber; they trust the person that dispenses and
supplies them with pharmaceutical information. In short,
they trust the system from which that medication comes.
They trust you; each and every one of you. So my
challenge to you today as you leave is to always act to
maintain that trust. Always act in a professional manner.
Always be trustworthy. Indeed, it’s really the health of the
patients that will benefit from that trust.”
Earlier, graduate Paige Lovellette led her now former
classmates in one final “Rhody, Rhody, Rhody” chant while
delivering the student commencement address. Lovellette
reflected on her years at the university with an eye to the
future, noting that while graduation is an end, “commencement is a beginning.” She urged her fellow graduates to
“dare to be different” and embrace all opportunities that will
come their way.
“The University of Rhode Island has given you an incredible
instrument, and it is important to take what you have
learned these past six years and continue to grow and
blossom,” Lovellette said. “We are at a time in our country
when anyone, from any place, at any age can make a
difference. There will be times when opportunities present
themselves. Do not be afraid to take them. Every opportunity brings us a chance to make that difference. Create those
opportunities and vow to be a difference maker.”
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His inspiration to
apply for such a
prestigious program
comes from the
quality of education
he’s received in the
College of Pharmacy.

Leadership, Service and Care
Reflecting on his college career, Joseph Nardolillo remembers being shy and not very
involved at the start of his freshman year. But his time within the College of Pharmacy has
taught him to take advantage of every opportunity, on campus and beyond.
Nardolillo’s impressive work has taken him to
pharmacies and medical centers throughout
Rhode Island, and to underserved communities
around the world. His time at URI has given him
the opportunity to volunteer his services in Jamaica,
Ghana and Guatemala, an experience he said has
shaped him as a pharmacist and a person.
On his first mission trip to Kingston, Jamaica,
Nardolillo said he was basically operating as a
“pharmacist out of a suitcase. It was a unique
experience because pharmacists often aren’t
brought along and are many times undervalued
on these types of trips,” he said. “The pharmacist
has a way bigger role than just handing out a
prescription. You have to make sure that they’re
dosing correctly; you have to make sure that it’s
not going to harm a patient.”
Giving back has been a huge part of Nardolillo’s
URI experience, and it’s one he’ll be continuing
after graduation when he begins his residency at
Indian Health Services in New Mexico. His
inspiration to apply for such a prestigious program
comes from the quality of education he’s received
in the College of Pharmacy.
12 / URI COLLEGE OF PHARMACY

Nardolillo said he feels prepared because of the
strong patient care emphasis the College instills
in students. His countless hours spent learning
material in a classroom, and teaching it as a
graduate student, were essential to his career,
but being taught how to apply that knowledge in
situations like in Jamaica has been central to his
education.
In New Mexico, where Nardolillo will fully manage
his patients and have one-on-one interactions,
the skills he’s gained from opportunities he’s had
here will come into play every day.
“It’s not just a classroom thing,” Nardolillo said.
“It’s not just getting a lecture and learning
material. It’s how are you going to use that
material in the real world? What skills do you also
need to build here to then be able to put to use
out there? You can have all the information in the
world, but if you can’t talk to a patient, if you can’t
talk to a doctor, if you can’t be connectable and
want somebody to listen to you and want
somebody to engage with you, that knowledge is
going to waste.”

Student-led Business
Wins Innovation
Voucher
A small business led by URI
College of Pharmacy graduate
students is among the latest
recipients of a $50,000 Innovation
Voucher fund awarded by the
Rhode Island Commerce Corp. to
promote research and innovation.

Students, Faculty Members
Promote Pharmacy at Statehouse
Dozens of URI Pharmacy students joined several
faculty members and Dean E. Paul Larrat at the 14th
annual Face of Pharmacy Day at the Rhode Island
Statehouse in April.
Created by the Rhode Island Pharmacist’s Association, the
Face of Pharmacy Day gives pharmacists and pharmacy
teachers and students the chance to promote their profession to state leaders and advocate legislators for or against
pharmaceutical issues, according to URI Pharmacy
Professor Anita Jacobson.
“It’s a chance for legislators to see pharmacists outside the
pharmacy,” Jacobson said. “It lets them see what we do,
like blood pressure and BMI — the non-traditional roles
pharmacists fill beyond the traditional pharmacy setting.”

Alcinous Pharmaceuticals, LLC, a
pharmaceuticals start-up founded by
three URI College of Pharmacy
doctoral students, uses computer-aided drug design to build a large library
of promising drug molecules that could
be used to develop cancer therapies
that are highly effective and well
tolerated. Alcinous is partnering with
Brenton DeBoef, associate professor in
the URI Department of Chemistry. The
project goal is to prove that molecules
designed using computers can be
produced in a laboratory.
The Innovation Voucher program
promotes research and development
partnerships among small businesses
and subject matter experts. The
incentive program awards up to
$50,000 to businesses with fewer than
500 employees and their knowledge
partners — often hospitals, colleges or
universities. The program issued its
first vouchers in January 2016 and has
since granted 43 awards.

Nicholas DaSilva, Kenneth Rose and
Benjamin Barlock.
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Millions in Research Funding for URI Neuroscientist
A $3.3 million grant from the National Institutes of Health will support a University of
Rhode Island neuroscientist’s research to identify early-stage biomarkers for a brain
disease often found to coexist with Alzheimer’s disease.
The five-year grant was awarded to William Van Nostrand,
Hermann Professor of Neuroscience at URI’s College of
Pharmacy and George & Anne Ryan Institute for Neuroscience. The funding will help fill a critical research niche in
early detection of cerebral amyloid angiopathy, a disease in
which amyloid deposits form in small and medium blood
vessels in the central nervous system, contributing to
dementia and brain hemorrhages. Although the disease is
common in the elderly, it often isn’t diagnosed until its late
stages, when bleeds can be detected by brain imaging.
“Early and accurate diagnosis of this condition has
remained elusive,” Van Nostrand said. “There is a need for
biomarkers for early stages of disease prior to the presence
of lesions detected by neuroimaging. The purpose of this
project is to fill this void by developing and validating robust
biological fluid markers for CAA.”
The project, is being conducted in collaboration with
Professor Marcel Verbeek at Radboud University Medical
Center in Nijmegen, Netherlands, based on previous work
by the Verbeek and Van Nostrand labs that identified
potential cerebral amyloid angiopathy biomarkers in brain
tissue. A biological fluid marker not only could potentially
provide an earlier, more accurate diagnosis of the disease,
but could also help guide treatment options, particularly in
therapies where the disease represents a heightened risk of
hemorrhage.

FACULTY
Expertise earns
National Recognition
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Van Nostrand is noted for being the
first researcher to purify and characterize amyloid precursor protein, the
progenitor of the amyloid-beta
protein that forms hallmark plaques
in Alzheimer’s disease. “Our goal is
ultimately to identify mechanisms of
disease that could be targets for new
treatments,” he said.

Deyu Li Announced as
Avedisian Endowed Chair
Professor Deyu Li is known around the College as a
dedicated, engaging teacher. He is known as a
talented researcher making significant breakthroughs in DNA science and cancer treatment. He is
now also known as the Paramaz Avedisian Endowed
Chair in Medical Organic Chemistry.
Li has been chosen for the position named for 1954 URI
graduate Paramaz Avedisian, Dean E. Paul Larrat has
announced, part of the $5 million gift Edward Avedisian
made to the college in 2017. Li is the perfect person to
continue the legacy of his late brother, a dedicated pharmacist and chemist, Edward Avedisian said.
“He’s got a great rapport with students; he’s doing a great
job bringing in research grants; and he’s producing impressive results in the lab. A guy like that can draw in the top
students,” Avedisian said. “When you’ve got curiosity,
creativity and you’re willing to work, huge developments can
come out of it.”
Li is the first named to the endowed chair, intended to help
build a team of scientists across multiple disciplines to work
toward the goal of finding better therapies for disease and
better treatments for patients.
“We’re gradually advancing toward the end goal of finding
better therapies, but this is not a one-day study. It takes
time. The endowed chair will help give us the time and
support to get there,” Li said. “It’s always been my goal to
study disease, find better drugs and improve treatment. This
gives me a lot of confidence and support to pursue this goal
I’ve had for a long time.”
Dean Larrat shares that confidence in Li, expecting the
Avedisian Chair will help the young professor succeed in his
mission.

“We’re gradually
advancing
toward the end
goal of finding
better therapies,
but this is not a
one-day study. It
takes time. The
endowed chair
will help give us
the time and
support to get
there.”
 – Deyu Li

“Deyu is truly one of the rising stars not just at URI but
throughout the entire pharmaceutical development industry,”
Larrat said. “He is an engaging teacher who will continue to
attract the top students to the College and to his lab. He has
already proven himself to be among the most talented
researchers in his field. I have no doubt the many breakthroughs Deyu will achieve will impact the medical
community for decades to come.”
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High Honor for Ryan
Institute Director
Paula Grammas, College of Pharmacy professor
and executive director of the University of Rhode
Island’s George & Anne Ryan Institute for
Neuroscience has been elected a Fellow of
the American Association for the Advancement of
Science in recognition of her pioneering research
into neurodegenerative conditions, including
Alzheimer’s disease.
Grammas is part of a prestigious group of scientists,
including five Nobel Laureates, selected as 2017 Fellows
for “their contributions to science and technology, scientific
leadership and extraordinary achievements across disciplines.” She is being recognized “for services to neuroscience, particularly in developing a novel approach to
understanding the pathology of Alzheimer’s disease and
explaining research to the community,” according to the
award letter from Rush D. Holt, chief executive officer.
Grammas is best known for her research into the role that
blood vessels and inflammation play in the development of
neurodegenerative diseases.
“I am honored to be recognized by the American Association for the Advancement of Science, which has been a
force for good in supporting the work of scientists and
fostering innovation and collaboration among scientists,
engineers and educators around the globe,” Grammas said.
“This acknowledgement is particularly meaningful coming
from my peers.”
Founded in 1848, the Association is the world’s largest
multidisciplinary scientific society. Past Fellows include
inventor Thomas Edison, anthropologist Margaret Mead
and astronomer Maria Mitchell.
Grammas has received numerous awards for her research.
She has been the principal investigator or co-investigator
on more than $26 million in research grants from the
National Institutes of Health, the Alzheimer’s Association,
the American Foundation for AIDS Research, and other
agencies. She has published more than 143 peer-reviewed
research papers and is the recipient of the Zenith Award
from the Alzheimer’s Association, recognizing her as one of
the nation’s leading researchers on Alzheimer’s disease.
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On the Rhode to Health
The URI Health Institute, part of the
Academic Health Collaborative,
recently acquired a mobile health unit
to help increase the collaborative’s
outreach into the community. College
of Pharmacy faculty members and
students will take part in health
outreach initiatives throughout Rhode
Island, which are expected to include
blood pressure screenings, HIV/AIDS
screenings, flu shot clinics and more.

Rhode To Health
Mobile Health Unit brings
care to communities.
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Pharmaceutical
Development
Institute
The market for new, better
medications is ever-expanding,
and the rapid expansion of the
industry has created a critical
demand for skilled professionals (from equipment operators
to advanced technical and
quality assurance personnel)
and additional infrastructure to
support drug development and
manufacturing.
URI’s College of Pharmacy is
helping fill that void with its state-ofthe-art Good Manufacturing Practice
(GMP) Facility. Located in the
basement of Avedisian Hall, the
7,000 square-foot clean room has
the purity and sterility of a hospital
operating room, necessary for
producing medications. A series of
fans and an advanced filtration
system constantly scrub the
environment. The air pressure of
each interconnected room and
laboratory is higher than the last,
ensuring air — and the contaminates it carries — is constantly
flowing out.

SPECIAL PROGRAMS
Making an Impact on-campus
and Beyond
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The facility supports the University’s
continuing efforts to strengthen and
expand its education, research and
development capabilities and allows
the limited production of pharmaceutical / biotechnology products.

The facility’s mission is to:
• Facilitate the development
of new pharmaceutics by
researchers at URI and their
academic and industry partners.
• Engage private partners to
enhance the economic
development of the Rhode
Island pharmaceutical and
biotechnology industries.
• Develop a world-class
teaching and training facility
for faculty, students and the
biotech/pharmaceutical
industry.
The URI GMP Facility fills a
critical void in the infrastructure
for pharmaceutical development,
manufacturing, research and
teaching within the State of
Rhode Island. Its services include:
• GMP operations: Assisting
academic, government and
industry partners with the
manufacture of solid dose
forms for veterinary and
human use.

Seminar By the Sea tackles
Trending Health Topics
With a theme of “advocating for our patients,” the
University of Rhode Island College of Pharmacy
Office of Continuing Professional Development
presented its 33rd annual Seminar by the Sea
Northeast Regional Conference in March.
The conference — March 14-16 at Gurney’s Newport
Resort and Marina on Goat Island, Newport — brought
together pharmacists, clinicians and students from around
the region to discuss some of the largest issues affecting
health care today. Training sessions during the seminar
provided continuing education credits for pharmacists.
A host of pharmaceutical and medical professionals
presented on such topics as the ongoing opioid crisis,
avoiding pharmaceutical errors, the physiological impacts
of marijuana on children and adolescents, and more.
Continuing education credits were available in such topics
as preceptor training and compounding best practices, and
a panel discussion addressed the local response to drug
supply challenges. Keynote addresses were delivered by
Sen. Sheldon Whitehouse (D-R.I.), below, and Jake
Nichols, CEO of Strategic Recovery Resources.
The College has scheduled the next Seminar by the Sea
for Thursday and Friday, March 14-15, 2019, at Gurney’s in
Newport. For more information and to register, log onto
uri.edu/pharmacy/cpd

• GMP analytical testing:
Providing pharmaceutical
testing services, including
turnkey stability studies.
• Education: Providing GMP
industrial experience in drug
manufacturing and analytical
testing for students in various
related undergraduate,
graduate and adult education
programs, as well as industryspecific training in collaboration
with pharmaceutical and
biotechnology firms.
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Newest Alumni

Alumnus, CVS Vice President Wins
2018 Campbell Award
The University of Rhode Island College of Pharmacy
presented alumnus Tom Davis, above right, with the
Dr. Norman A. Campbell Award for Ethics and
Excellence in Healthcare, honoring his “profound
dedication” to the pharmacy profession and society
as a whole.
Davis, a 1991 graduate from URI, is vice president of Pharmacy
Professional Services for CVS, where he is responsible for the
patient safety, quality assurance, professional practice standards
and clinical support for the company’s retail division. He also
leads professional practices for Omnicare, CVS Health’s longterm care pharmacy business.
Before his 20 years at CVS, Davis worked for Brooks Pharmacy
and as chief of the Compliance and Regulatory Section for the
Rhode Island Division of Drug Control. He has also served on
the Rhode Island Board of Pharmacy and in 2015 was appointed to the Rhode Island Opioid Overdose Prevention Taskforce,
showing the commitment to quality and ethics the Campbell
Award recognizes, according to Norm Campbell, professor
emeritus at URI for whom the award is named.

Some of the Newest B.S.P.S and Pharm.D
graduates pose with their Professors.

“He has been really committed to the law and ethics throughout
his career,” Campbell said. “He is absolutely deserving. He has
maintained an interest in doing the right thing, which is something that isn’t always easy to do.”

ALUMNI
Bringing URI success
into the community
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Professors David Rowley and Bongsup
Cho present 2018 Doctor of Philosophy and
Pharmaceutical Sciences graduate Ang Cai
with his ceremonial hood during the annual
Hooding Ceremony in May.

URI Graduate Dedicated to Improving Length, Quality of Life
Whether it’s studying new medications to treat Alzheimer’s disease, helping develop
vaccines that aim to prevent the debilitating disease, or educating the next generation of
elder care professionals, few have done more to advance the medical care of older adults
than Dr. John Stoukides.
As director of
Geriatrics at Roger
Williams Medical
Center, Roger
Williams Senior
Health Care, and the
Rhode Island Mood
& Memory Research
Institute, Stoukides, a
1985 URI graduate,
has dedicated his
professional life to
improving not only the length, but also the quality of
life as we age. For his contributions to the field and
health of the community in general, Dean E. Paul
Larrat presented Stoukides with a Distinguished
Achievement Award in 2017.
In his 20 years practicing geriatric medicine,
Stoukides has taken part in clinical research trials

that have brought all FDA-approved Alzheimer’s
medications to market. He is working to develop
vaccines to prevent Alzheimer’s and to slow its
progression. He is also a professor at Boston University and Brown University, and is a founding faculty
member of the Rhode Island Geriatric Center at URI.

Stoukides continues his groundbreaking research at the University,
partnering with the Ryan Institute for
Neuroscience to test new
Alzheimer’s treatments using
vascular activation.
He has also served on the College of Nursing
Advisory Council, participated in the creation of
the Academic Health Collaborative and continues
to generously support the Colleges of Pharmacy
and Health Sciences.

Some of the newest alumni,
the BS - Pharmaceutical Sciences
2018 graduates, gathered for an
end-of-year celebration at the
Alumni Center in May.
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COMMITTED BY
PURPOSE
6.7%

2.7%

Total
Commited by
Purpose
FY17
90.6%

z Endowed Gifts / 90.6%
z Operating Gifts / 6.7%
z Annual Fund / 2.7%
2017
Annual Fund

$105,006

$94,446

Endowed Gifts

$3,538,482

$70,182

Operating Gifts

$261,496

$254,696

GIVING ALLOCATIONS
90.0%
1.0%
11.3%

Total
Commited to
College
FY17

9.0%

78.8%

GIVING

z
z
z
z

Outright Gifts / 1.0%
New Documented Pledges / 11.3%
Matching Gifts / 9.0%
New Planned Giving Activity / 78.8%

Support for College means
0pportunities for all
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An honor roll of donors is published online at
uri.edu/pharmacy/college-of-pharmacy-honor-roll/

Development Director Named
The University of Rhode
Island Foundation has
announced the appointment of Eric Schonewald
as managing director
of development for the
Academic Health Collaborative. Schonewald will
work closely with College
of Pharmacy Dean E. Paul
Larrat, College of Nursing
Dean Barbara Wolfe and
College of Health Sciences
Dean Gary Liguori.

73.7%
20.9%

Total
Commited by
Purpose
FY18
73.7%

z Endowed Gifts / 73.7%
z Operating Gifts / 20.9%
z Annual Fund / 5.3%
2018
Annual Fund

$121,427

Endowed Gifts

$1,685,857

$125,182
$1,561,755

Operating Gifts

$478,802

$316,302

0.1%
3.4%
18.8%

Total
Commited to
College
FY18
77.7%

z
z
z
z

Outright Gifts / 77.7%
New Documented Pledges / 18.8%
Matching Gifts / 0.1%
New Planned Giving Activity / 3.4%

Schonewald launched his
23-year development career at Yale University School of Medicine, where he ultimately served as director of development for
the Department of Internal Medicine. While at Yale, his team
led the School of Medicine’s educational component of the
Yale Tomorrow capital campaign. Before accepting the position
at the URI Foundation, he served as senior director of development for the Bloomberg School of Public Health at Johns
Hopkins University.
URI’s Academic Health Collaborative, launched in 2016, serves
more than 5,000 students in nine health disciplines. The URI
Health Institute serves as a hub for innovation, providing
cross-disciplinary opportunities in education, research, entrepreneurship and service. Its work engages external health
agencies, including hospital systems, and other universities
and colleges in the state.
“As society ages and confronts 21st Century diseases, there
is a constant need to innovate and develop new and better
medications,” Schonewald said. “The researchers here in
the College of Pharmacy continue to meet that burden with
ever-more creative and revealing research. But they can’t do it
alone. Philanthropic support is absolutely essential to support
these talented researchers as they work toward the future of
health care.”
For more information about giving to the College of Pharmacy
or any disciplines in the Academic Health Collaborative, contact
Schonewald at eschonewald@uri.edu or 401.874.9017.

The College of Pharmacy is grateful for the alumni, friends, corporations and foundations whose generosity
supports students, faculty and essential College initiatives.
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Why I Give: Colleen Moffitt ’88,’94
Colleen Prior Moffitt has held several roles in the pharmaceutical industry, having worked
in retail, hospitals, and now in drug development as a medical liaison between physicians
and researchers at Alnylam Pharmaceuticals. The education she received in the URI
College of Pharmacy was integral to such a diverse career.
“My pharmacy degree prepared me very well for
the role I have now, but before, I had many other
roles,” said Moffitt, who earned her bachelor’s
degree in ’88 and her master’s in ’94. “It gives
you the flexibility to practice pharmacy in a lot of
different ways — in a hospital, in retail, in a
research setting. I think that’s what a pharmacy
degree prepares you for.”
The head start URI gave Moffitt has always
inspired her and her husband, fellow URI
graduate Chuck Moffitt, to give back, in the form
of both time and money. Her service to the
College began while she was a master’s degree
candidate, helping teach pharmacy classes and
even filling in when a professor passed away.
She continued through the years, serving on the
Continuing Education Advisory Committee and
maintaining a role on the Dean’s Advisory
Committee, which she now chairs. She contributes financially to the College’s Annual Fund.
“I’ve always tried to somehow stay involved and
help the College,” Moffitt said. “Serving on the
Dean’s Advisory Committee gives me the chance
to provide the College a window into what’s going
on in the business world. It gives the College
perspective on what the needs may be in the
community, and helps students prepare for those
challenges.”
Helping students has been a prime factor in
Moffitt’s service and giving. She makes multiple
donations each year to the College of Pharmacy
Annual Fund, which is the primary source of
unrestricted, current-use money for Dean E. Paul
Larrat to address the most urgent student or
faculty needs at any given time.

“The Annual Fund helps provide opportunities for
students they wouldn’t necessarily be able to
have on their own,” Moffitt said. “Whether it’s
going to a pharmaceutical conference or educational traveling, it gives students experiences they
may not have been able to afford on their own.
Those experiences are very valuable for
students.”
Being able to help the next generation of healthcare workers is very rewarding to Moffitt, who
would encourage anyone in the community —
specifically those who have benefitted directly
from the College or the University — to support
URI the best they can.
“We all get millions of envelopes every year, it
seems, and there are competing interests, so I’ve
been more thoughtful about who I give to,” said
Moffitt, who lives in nearby Wakefield, R.I. “I want
to donate to somewhere I can directly feel the
impact, and URI is that. It’s such a positive
element in our community, and that’s why I
support the University. I would encourage anyone
to. It doesn’t have to be a lot; every little bit helps.
Just get in the habit.”
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TIME + TALENT
Our College of Pharmacy community is indebted to a vast network of alumni,
partners and friends who dedicate their time and expertise to support our mission.
BSPS ALUMNI MENTORS

Sarah Alicea

Robert Cappa

Matthew Alcusky ’14

Nicole Allie

Paul Capuano

Shivani Amin

Tonya Carlton

Dana Amore

Robert Carpenter

Kristyn Anderson

Beatriz Carrasquillo

Valerie Anselmo

Kayla Cartwright

Stephen J. Allen ’76
Richard Bianco ’86
Jeffrey E. Cehelsky ’87
Susan Johnson ’81

Nicole Asal

Linda Carver

David F. Ludwig ’80

Aisha Ashraf

Bob Cattan

Sarah Marchand ’09

Ifeoma Asoh

Vivianne Celario

Robyn Peters ’86

Jose Badillo

Scott Cerce

Kim Queren ’83

Joan Baird

Kristen Champagne

Ryan Baker

Michele Chantra

Brittney Baker

Camille Charbonneau

Julie Barber

Maggie Charpentier

Colleen Barboza

Ashley Child

FRIENDS OF THE
YOUNGKEN GARDEN

Janine Barnaby

Bongsup Cho

Joanna Barnas

Raymond Ciarleglio

Joan Lausier

Pamela Barton

Nicole Clark

Amey Larrat

James Beaulieu

Sara Claypoole

Muriel Benjamin

Joanne Hoffman Beechko

Kathleen Cleary

James Berghelli

Vanessa Coelho

Jeremy Blais

Lisa Cohen

Stephanie Blais

Christine M. Collins

Carl Symenco ’94
Joe Tuazon ’03
Chris Yun ’88

Hiroko Shimizu
Yusuru Shimizu
Robin Rodgers

Stephanie Bleau

Nan Conte

Richard Youngken

Deepa Blomstedt

Karla Cooper

Kenneth Rose

Carol Botelho

Chandra Cooper

Victoria Leyden

Megan Bouchard

Todd Cooperman

Julia Law

Jennifer Boyle

Lesley “Nicky” Corkum

Jeffrey Bratberg

Kenny Correia

Todd Brothers

Thomas Cory

Sarah Brouillet

Carrie Coselman

Anne Brown

Jackie Costantino

Casey Burns

Kelly Cotter

Amanda Butkiewicz

Erin Cournoyer

Marlene Callahan

Kevin Coyne

Steven Cano

Megan Crete

Joseph Cao

Mark Curtis

PRECEPTORS
Jeffrey Aberle
Renee Abjornson
Shawn Ackerman
Kathleen Adams
Cyrus Agarabi
David Ahern
Kelsey Albuquerque
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Sally Cushnie

Joshua Friedman

Zachariah Jacob

Melissa DaCosta

Dana Gagnon

Anita Jacobson

Ruth Dapaah-Afriyie

Linh Gagnon

Brian Jang

Jeffrey Del Ricci Jr.

Alexandra Garcia

John Jensen

Christopher DeLucia

Mark Gaudet

Erik Johnson

Megan Derba

Marc Gentile

Sara Jones

Noemi DeSimone

Fouachee Gillespie

Ellen A. Jones

Odilia DesRoches

Peter Godbout

GaEun Joung

Shannon Dion

Surya Gopal

Bonnie Judd

Brian Dix

Jessica Goren

Melissa Kamper

Amy Dolahan

Robert Goris-Kolb

Eris Karanxha

Edward Doubrava

Karen Gradischer

Katie Karkowski

Patrick Dougherty

Rachel Grant

Sarah Kaufer

Alex Dozier

Sarah Green

Maxx Keizer

Kristen Driscoll

Trevor Greene

Patrick Kelly

Christine Duffy

Rebecca Greene

James Kennedy

Danielle Dufresne

Cory Grevenitz

Afzav Khan

Robert Dufresne

Sabrina Griswold

Melissa Kilsey

Russell Dunn

Barbara Gross

Lee Kimball

Chris Durigan

Joshua Guerin

Brittany Kirker

Courtney Durkin

Samantha Gurney

Valerie Klots

Dina Eisa

Nicholas Haar

Stephen Kogut

Christine Eisenhower

Susan Hanson

Dylan Krawczyk

Amy Emerson

Cindy Har

Rochelle Kugler

Erica Estus

Britt Harrington

Kathleen Kundrat

Kenneth Eugenio

Anthony Harrison

Scott Lancellotta

Natalija Farrell

Heather Hatem

Kristina LaPerriere

Chris Federico

Susan Hauf

Kerry LaPlante

Dawn Feret

Joshua Hendrickson

Alexandra Lavoie

Jennifer Fiebert

James Higginbottom

Eileen Lawler

Pamela Fiske

Tara Higgins

Stephen Lee

Kylie Fogarty

Cory Hobson

Daniel Lefkowitz

Renee Ford

Kathleen Hoffman

Anthony Leggio

Michael Ford

Christine Holahan

Ginger Lemay

Jean Formisano

Lauren Hooke

Jeffrey Lentowski

Rachel Fortin

Renee Hoyceanyls

Lisa Letarte

Lauren Foss

Anne Hume

Lori Lewicki

Keith Foster

Justin Huynh

Keith Lewis

Rachel Foster

Teri Hwang

Joseph Lewis

Brian Fournier

Robert Iacobucci

Justin Liauw

Gilles Fraser

Elie Jabbour

Rebecca Limauro
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Brittany Linthicum

Ralph Misto

Priyanka Patel

Riley Lizotte

Maricelle Monteagudo-Chu

Vimal Patel

Craig Long

Chloe Morgan

Jaymin Patel

Christine Long

John Morgan

Jayne Pawasauskas

Amanda Loomer

Angelo D. Morgantini

Gregg Pennington

Francois Lortongsy

Kathryn Morrison

Nancy Percy

Clifford Lovett

Michael Muller

Kathy Peterson

Jeff Low

Kelly Mullican

Alexander Pham

Greg Low

Griffan Mullins

Marisa Piers-Gamble

Phuong Luc

Brett Murdy

Leslie Pires

Christina Luisi

Heather Murphy

Travis Pires

Daniel Lyktey

Nigel Musgrave

Lisa Pistorino

Celia MacDonnell

Foster Myers III

Brittany Plapis

Jonathan Machnik

Michael Natale

Jerry Powers

Leana Mahmoud

Joseph Navarra

Ross Pray

Tara Mainello

Linda Nelson

Jessica Price

Lauren Major

Deborah Nery

Mylissa Price

Michelle Mancuso

Nguyen Michelle Nguyen

Christina Procaccianti

Allison Marchand

Karen Nolan

Dawn Pyne

Cindy Margaritonda

Sean Nolan

William Quirk

Kay Marioni

Nancy Nystrom

Lorraine Quirk

Alyssa Marston

Joseph O’Neill, Jr.

Marybeth Rainey

Kerry Martin

Alan Obringer

Allison Randall

Megan Masse

Angela Olenik

Maggie Randazzo

Kelly Matson

Evelyn Olson

Stephanie Richard

Stacey Maxwell

James Olszewski

Amy Ricupero

Laura McAuliffe

Daniella Ondrik-Pina

Michael Riendeau

Jeffrey McCarthy

Carmen Oquendo

Anella Robinson

Heather McCarthy

Kelly Orr

John Rocchio

Megan McCaskill

Maria Osundele

Kassandra Rodriguez

Rachel McGarty

Susan Otocki

Britny Rogala

Gerald McGaunn

Norma Owens

Mark Rogers

Kristina McGill

Jeff Owren

Jeff Rosen

Donald McKaig

Katherine Padilla

Traci Rosenberg

Shawn McKallagat

Donna Paine

Andrew Ross

Christine McLellan

Anna Palazzo

Dana Royal

Brian Meneses

Melinda Paquette

Nicole Rubinow

Aimee Mertz

Paul Parchesky

Adam Rucando

Eric Metterhausen

Shawn Parekh

Vincent Salerno

Roger Michaud

Diane Parente

Anna Sample

David Milak

Yesha Patel

Alexandra Santamaria
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Mark Santilli

Douglas Thomas

Michael Zeolla

Anna Santoro

Sarah Thompson

Yuan Zhang

Kelley Sanzen

Stephanie Tiano

Jillian Zile

James Sarigianis

Frank Toce

Andrew Zullo

Marizela Savic

Andrew Tomlinson

Cynthia Scaffidi

Amanda Tommasiello

Alison Schiesl

Robert Tortolani

Matthew Schmitt

Nancy Tortolani

Amy Schwalbe

Kevin Tran

Megan Schwartz

Lily Travis

William Schwetz

Shayna Trenn

Patrick Seckler

Priti Trivedi

Navindra Seeram

Mei Tsai

Mary Semet

Kate Ulbricht

Hope Serafin

Joshua Vallee

Ewa Dzwierzynski, Pharm.D. ’96

Ronald Serak

Jerril Varghese

George Grandolfi, Ph.D. ’81

Evelyn Sesay

Christine Vaudo

Heather Larch ’99

Brian Seyboth

Adolph Vezza

Justina Molzon ’73, M.S. ’76

Deven Shah

Ann Marie Viall

Nancy C. Motola, Ph.D. ’83

Prutha Shah

William Viens

Ann-Marie Shea

Jeff Vinosky

Edward Sheehan

Tristan Vo

Stacie Siedzik

Robert Waite

Sarah Simpson

Matthew Ward

Lynn Pezzullo ’91

Sandeep Singh Bains

Kristina Ward

Robert W. Potter Jr. ’83

Kathryn Smith

Susan Ware

Edward Quinlan ’71

Dawn Sollee

Nikko Ware

Edward M. Rudnic ’78, Ph.D. ’83

Abhishek Srivastava

Carolyn Welch

Sarah Thompson

Michael Stearns

Stephanie Wildenhain

Suzanne Stevens

Steve Willis

Lauren Stuczynski

Jennifer Wilson

Lauren Sullivan

Richelle Winkler

Katarzyna Szablowski

Jesse Wisniewski

Jada Taglione

Bridgit Witbeck

Angelica Taskin

Stasia Wojcik

Tracey Taveira

Tamatha Yeaw

Eridania Teixeira

Kevin Yeh

Jennifer Temple

Daniel Yokell

Andrew Terranova

Karen Youmbi

Theodore Terziev

Mahmoud Zegar

Rosalba (Rose) Thiboutot

Wesley Zemrak

COLLEGE OF PHARMACY
ADVISORY BOARD
Colleen Prior Moffitt ’88, M.S. ’94,
Chair
Rich Krupski ’80,
Vice Chair
Dea Belazi, Pharm.D, ’01
Norman Campbell, Ph.D. ’57,
Christine M. Collins ’90

Henrique T. Pedro ’76
Eleanor Perfetto ’90, M.S. ’88
Susan Petrovas

John Zevzavadjian ’88
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COP Advisors: ‘The People I Go to’
When Dean E. Paul Larrat needs help with a College
project, advice on pharmaceutical issues, a sounding
board when making decisions, or anything else to
help the College succeed, he knows where to turn:
the College of Pharmacy Advisory Board.
“They’re the people I go to all the time, for simple things like
finding a spot for a student internship, or more complicated
things like consulting on technical issues,” Larrat said. “They
act as consultants, cheerleaders, ambassadors, advisors for
our faculty — they do it all.”
Advisory Board Vice Chairman Richard Krupski ’80 credits the
College of Pharmacy with the success he has had over the
years. The vice president of Employee Benefits for Hilb Group
New England has worked in the health care space his entire
career, for such entities as Blue Cross Blue Shield, Care New
England and Promark LLC. He wanted to find a way to give
back to the College that had given him so much. Helping the
College attract top talent to URI, continually bring in research
funding and remain “in lockstep” with the pharmaceutical
industry beyond the university are just some of the ways the
Advisory Board helps with the College’s success, he said.
“Being part of the committee, for me, is part of giving back.
While you look back on your experiences, you also want to
pay it forward,” Kurpski said. “The advisory board is meant to
be a service to the dean. The emphasis is on ‘advisory.’ We’re
not going to create the strategic direction of the College, but
we are going to provide input, ideas and things the dean can
potentially utilize to better enable the College to be successful.
It’s a great think tank of ideas. It enables the dean to direct the
College and help it with its strategic direction.”

Peter Morgan, senior gardener who was instrumental in the
design and maintenance of the Youngken Medicinal Garden
outside Avedisian Hall, retired this summer but plans to
continue volunteering in the garden.
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‘This Garden is a Work of Art’
The Friends of the Garden rededicated the Heber W. Youngken Medicinal Garden in June, recognizing
its 61st year and fifth year located outside Avedisian Hall, home of the College of Pharmacy. The ceremony served a dual purpose, also bidding farewell to longtime Senior Gardener Peter Morgan,
who retired after more than 30 years with the College. Peter was instrumental in the design and maintenance of the garden, whose bounty produces plants that are not only beautiful, but also hold medicinal
properties.
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Learning,Teaching
in Indonesia
College of Pharmacy Dean E. Paul
Larrat joined fellow deans from the
Academic Health Collaborative
Gary Liguori (Health Sciences) and
Barbara Wolfe (Nursing), along
with about a dozen students in
Indonesia for a J-Term learning
and teaching trip.
The group visited Bali, Jakarta and Yogyakarta, touring community health centers, conducting blood pressure screenings and relaying information on stroke
and asthma prevention. The students
collaborated with Indonesian pharmacy students and recent graduates from
Universitas Islam Indonesia to create
presentations regarding stroke prevention
and education.
“The students were committed to making
their time over there valuable,” Larrat
said. “They were willing to enmesh themselves in Indonesian culture, which really
enhanced their experience. It was a great
cultural exchange and a really valuable
learning experience for them and us.”

GLOBAL IMPACT
Making a difference
beyond our borders
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Pharmacy Dean E. Paul Larrat, center
joined fellow deans Barbara Wolfe (Nursing)
and Gary Liguori (Health Sciences) on a
J-Term trip to Indonesia in January.

Learning in 3D
The Dr. Ernest Mario 3D Visualization Auditorium
takes the College’s use of 3D technology to a new
level with a huge IMAX-like projection system,
delivering 3D content ranging from the molecular
to the anatomical; enhancing understanding and
student engagement.
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Stay Connected:

twitter.com/URI_Pharmacy  
facebook.com/University of Rhode Island College of Pharmacy
uri.edu/pharmacy/news-and-events/

How to Give:
All gifts to the University of Rhode Island should be made payable and mailed to the URI Foundation,
P.O. Box 1700, Kingston, RI 02881. You can use the enclosed envelope or make your online gift at
urifoundation.org/giveonline.
URI is an equal opportunity employer committed to the principles of affirmative action.
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